Drug treatment of diseased sites deep within the body

Details Drug treatment of diseased sites deep within the body Drug treatment of diseased sites deep within the body

1994-03-29

1996-12-31

McDermott, Corrine M.

Surgery

Means for introducing or removing material from body for...

Treating material introduced into or removed from body...

604 19, 604 53, 128898, A61N 130

Patent

active

055889620

ABSTRACT:
A diseased site, such as vascular dilatation site, is treated by first locally delivering to the site an agent that is effective to localize a desired drug and then systematically administering the drug.

REFERENCES:
patent: 3699956 (1972-10-01), Kitrilakis et al.
patent: 4026296 (1977-05-01), Stoy et al.
patent: 4299226 (1981-11-01), Banka
patent: 4330497 (1982-05-01), Agdanowksi
patent: 4364392 (1982-12-01), Strother et al.
patent: 4417576 (1983-11-01), Baran
patent: 4423725 (1984-01-01), Baran et al.
patent: 4448195 (1984-05-01), LeVeen et al.
patent: 4481323 (1984-11-01), Sterling
patent: 4515593 (1985-05-01), Norton
patent: 4589873 (1986-05-01), Schwartz et al.
patent: 4592340 (1986-06-01), Boyles
patent: 4603152 (1986-07-01), Laurin et al.
patent: 4693243 (1987-09-01), Buras
patent: 4714460 (1987-12-01), Calderon
patent: 4769013 (1988-09-01), Lorenz et al.
patent: 4784647 (1988-11-01), Gross
patent: 4820270 (1989-04-01), Hardcastle et al.
patent: 4832688 (1989-05-01), Sagae et al.
patent: 4876126 (1989-10-01), Takemura et al.
patent: 4909258 (1990-03-01), Kuntz et al.
patent: 4923450 (1990-05-01), Maeda et al.
patent: 4932934 (1990-06-01), Dougherty et al.
patent: 4950256 (1990-08-01), Luther et al.
patent: 4955377 (1990-09-01), Lennox et al.
patent: 4983166 (1991-01-01), Yamawaki
patent: 4993412 (1991-02-01), Murphy-Chuorian
patent: 4994033 (1991-02-01), Shockey et al.
patent: 5021044 (1991-06-01), Sharkawy
patent: 5026607 (1991-06-01), Kiezulas
patent: 5041100 (1991-08-01), Rowland et al.
patent: 5047045 (1991-09-01), Arney et al.
patent: 5049132 (1991-09-01), Shaffer et al.
patent: 5091205 (1992-02-01), Fan
patent: 5102402 (1992-04-01), Dror et al.
patent: 5120322 (1992-06-01), Davis et al.
patent: 5135516 (1992-08-01), Sahtjian et al.
patent: 5163906 (1992-11-01), Ahmadi
patent: 5167960 (1992-12-01), Ito et al.
patent: 5171217 (1992-12-01), March et al.
patent: 5180366 (1993-01-01), Woods
patent: 5199951 (1993-04-01), Spears
patent: 5209720 (1993-05-01), Unger
patent: 5213576 (1993-05-01), Abiuso et al.
patent: 5213580 (1993-05-01), Slepian et al.
patent: 5226430 (1993-07-01), Spears
patent: 5232444 (1993-08-01), Just et al.
patent: 5252557 (1993-10-01), Kita et al.
patent: 5286254 (1994-02-01), Shapland et al.
patent: 5295944 (1994-03-01), Teicher et al.
patent: 5298018 (1994-03-01), Narciso, Jr.
patent: 5301688 (1994-04-01), Stephen et al.
patent: 5304121 (1994-04-01), Sahatjian
patent: 5328471 (1994-07-01), Slepian
patent: 5356433 (1994-10-01), Rowland et al.
patent: 5376376 (1994-12-01), Li
patent: 5409012 (1995-04-01), Sahatjian
patent: 5470307 (1995-11-01), Lindall
McMath et al., "Experimental Application of Bioprotective Materials to Injured Arterial Surfaces with Laser Balloon Angioplasty", Circulation (Supp. III) 82:0282 (abstract) (Oct. 1990).
Thompson et al., "Heparin and Growth Control of Vascular Cells," Ann. N.Y. Acad. Sci. 556:255-267 (1989).
Tidd et al., "Comparison of Hydrophilic Polymer-Coated Latex, uncoated Latex and PVC Indwelling Balloon Catheters in the Prevention of Urinary Infection," J.Urol. 48:285-291 (1976).
Waller et al., "Vessel Wall Pathology After Angioplasty," Cardio. 57, 60, 69-72, 81 (Aug. 1990).
Waller et al., "Morphologic Observations Late after Coronary Balloon Angioplasty Mechanisms of Acute Injury and Relationship to Restenosis," Radio. 174:961-967 (Mar. 1990).
The Andreas Gruentzig Cardiovascular Center News Letter (Spring 1990).
European search report dated Sep. 15, 1993.
Deutsch et al., "Low Stress Angioplasty at 60.degree. C: Attenuated Arterial Barotrauma".
International Search Report for International Application No. PCT/US91/09804.
Wolinsky et al., "Local Introduction of Drugs into the Arterial Wall: A Percutaneous Catheter Technique".
Chapman et al., "A Bioabsorbable Stent: Initial Experimental Results", Circulation (Supp III) 82:0283 (abstract) (Oct. 1990).
Guyton et al., "Inhibition of Rat Arterial Smooth Muscle Cell Proliferation by Heparin: In Vivo Studies with Anticoagulant and Nonanticoagulatn Heparin," Circ. Res. 46:625-634 (May 1980).
Guyton et al., "Inhibition of Rat Arterial Smooth Muscle Cell Proliferation by Heparin: In Vivo Studies with Anticoagulant and Nonanticoagulant Heparin," Circ. Res. 46:625-634 (May 1980).
Shibasaki et al., "Effects of Cimetidine on Lidocaine Distribution in Rats", 1988, J. Pharmacobio-Dyn., 11(12):785-93.

Affiliated with

Also associated with

Rating

Drug treatment of diseased sites deep within the body does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Drug treatment of diseased sites deep within the body, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Drug treatment of diseased sites deep within the body will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1138741